Literature DB >> 19174774

Treatment for PSA screen-detected prostate cancer: what are the options?

R Tim D Oliver1, David E Neal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19174774     DOI： 10.1038/ncpuro1297

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN： 1743-4270


× No keyword cloud information.
  32 in total

1.  Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

Authors:  S E Oliver; D Gunnell; J L Donovan
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

Review 2.  Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review.

Authors:  Vincenzo Ficarra; Stefano Cavalleri; Giacomo Novara; Maurizio Aragona; Walter Artibani
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

3.  Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.

Authors:  Stanley L Liauw; John E Sylvester; Christopher G Morris; John C Blasko; Peter D Grimm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-08-02       Impact factor: 7.038

4.  Does surgery disseminate or accelerate cancer?

Authors:  R T Oliver
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

5.  Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.

Authors:  Sophie G Fletcher; Stacey E Mills; Mark E Smolkin; Dan Theodorescu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-11       Impact factor: 7.038

6.  Cost analysis of radical retropubic, perineal, and robotic prostatectomy.

Authors:  Scott V Burgess; Fatih Atug; Erik P Castle; Rodney Davis; Raju Thomas
Journal:  J Endourol       Date:  2006-10       Impact factor: 2.942

7.  Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.

Authors:  Joseph Riss; Chand Khanna; Seongjoon Koo; Gadisetti V R Chandramouli; Howard H Yang; Ying Hu; David E Kleiner; Andreas Rosenwald; Carl F Schaefer; Shmuel A Ben-Sasson; Liming Yang; John Powell; David W Kane; Robert A Star; Olga Aprelikova; Kristin Bauer; James R Vasselli; Jodi K Maranchie; Kurt W Kohn; Ken H Buetow; W Marston Linehan; John N Weinstein; Maxwell P Lee; Richard D Klausner; J Carl Barrett
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

8.  Mortality after cure of testicular seminoma.

Authors:  Gunar K Zagars; Matthew T Ballo; Andrew K Lee; Sara S Strom
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

9.  Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Authors:  Simon M Collin; Richard M Martin; Chris Metcalfe; David Gunnell; Peter C Albertsen; David Neal; Freddie Hamdy; Peter Stephens; J Athene Lane; Rollo Moore; Jenny Donovan
Journal:  Lancet Oncol       Date:  2008-04-16       Impact factor: 41.316

10.  Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).

Authors:  Jenny L Donovan; Tim J Peters; Sian Noble; Philip Powell; David Gillatt; Steven E Oliver; J Athene Lane; David E Neal; Freddie C Hamdy
Journal:  J Clin Epidemiol       Date:  2003-07       Impact factor: 6.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.